Screening for Bladder Cancer
Completed
Conditions studied: Bladder Cancer
In brief
In the study proposed, up to 1,500 men age 60 and over with strong smoking histories will test their urine for the presence of blood daily for two 10-day testing periods with the Ames Hemastix. Individuals with even a solitary positive test will undergo a thorough urologic evaluation to determine the cause of hematuria and follow-up will continue for 2 years after completion of the study.
Key facts
- Study ID
- NCT00848627
- Run by
- Baylor College of Medicine
- People needed
- 197
- Starts
- 2007-03-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2020-02-25
Who can join
Age: 60 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Men age 60 and over, - who are current cigarette smokers OR - who have a history of at least 20 pack years smoking OR - who have over a 30 pack/year history who have stopped smoking within 10 years of the registration date OR - who have a 40 pack year history of smoking regardless of the quit date, will be eligible for participation.
- Patients with prostate or renal cancer must have been treated more than 5 years previously and be considered disease-free at the time of entry. In the case of prostate cancer, patients may have only received prostatectomy as their treatment and must have undetectable PSA's at study entry.
- In the case of calculus disease, patients must be believed to be stone free at time of study entry and could not have had a stone attack within the previous 2 years.
- Patients receiving anticoagulation therapy, such as Warfarin, Plavix, Lovenox, aspirin, etc. will be able to take part in the study and, will be thoroughly worked-up if the only explainable cause of hematuria is receiving anticoagulation medication.
You may not qualify if…
- history of urothelial cancer
- any malignancy other than non-melanoma skin cancers treated within the past 5 years
- benign tumors of the urinary tract that are still existent
- known urinary calculi
- medical or oncological conditions known to produce hematuria (e.g. glomerulonephritis, treatments with cyclophosphamide, methotrexate and pelvic radiation therapy)
- visual, psychological, neurological, musculoskeletal, etc. impairments that would make home testing impractical
Where it is running
- University of Rochester Medical Center — Rochester, New York, United States
- M.D. Anderson Cancer Center — Houston, Texas, United States
- Laval University — Québec, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.